Cipla shares rise 2% on deal to acquire South Africa’s Actor Pharma
Cipla South Africa has signed a binding term sheet with Actor Holdings to acquire 100% of the issued ordinary shares of Actor Pharma.
cipla 3
September 2023
July 2023
February 2023
November 2022
September 2022
December 2021
November 2021
June 2021
April 2021
Cipla shares jump 9% after Q1 result beats estimates
In the earnings call, the management of Cipla raised its EBITDA margin target for the current fiscal to 23% from 22% estimates earlier.
Cipla shares fall 7% on USFDA observations for Pithampur unit
The U.S. drug regulator has issued Form 483 with 8 observations after the inspection of its Pithampur manufacturing facilities from February 6-17.
Cipla's Goa plant classified as 'Official Action Indicated' by USFDA; stock falls
USFDA may continue to withhold product approvals from this facility till the outstanding observations are resolved, says Cipla.
Surprise! Despite Covid-19 sales, Indian pharma an underperformer
A majority of pharma stocks reported double digit negative returns, while the overall market (BSE Sensex) delivered a 9% plus return.
Oral pills for Covid-19 by Sun Pharma, Cipla, Torrent & Strides
Sun Pharma will sell Molnupiravir under the brand name Molxvir in India, Torrent Pharma will sell it as Molnutor, while Cipla will market it as Cipmolnu.
Competitors Within
Home-grown smaller players are giving biggies a run for their money in the US generics market.
Get ready to surf India’s health tech wave
A great pharma and medical supply chain, large population, intent among health professionals to innovate, and willingness among customers to try new solutions will ensure the sector's success.
Making India breathe free beyond Covid-19
The pandemic is a timely and apt reminder to pay heed to our respiratory health, and particularly the lungs.
Reimagining Indian pharma
India’s pharma industry is reimagining itself. This is not just borne out of the necessities brought forth by the pandemic, but is a blueprint to thrive and to succeed in this new world.
